The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will publish its financial and ...

A study by researchers at Baylor College of Medicine and collaborating institutions reveals a previously unrecognized way ...

Vibration plates are buzzing across gyms, TikTok, and home fitness spaces, promising everything from better balance to faster recovery. Experts say they can offer real—but modest—benefits, ...

Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

In a makeshift demonstration kitchen in Concord, California, cooking oil splatters in and around a frying pan, which catches ...

Nexxen, the advertising technology platform powered by unique data and media, today announced that H/L, a renowned multiservice and independent agency, is the first to programmatically activate native ...

As global temperatures rise, extreme heat could threaten athletes, fans, workers and officials during this year’s World Cup ...

Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has announced the launch of its Tumor Protein Mapping Platform as a suite of mass ...

Explore why CFOs and treasury teams are prioritizing liquidity, working capital strategies, and payment term flexibility amid ...